New Delhi, Jun 11 (UNI) Unichem Laboratories Ltd today said it has received final approval from US Food and Drug Administration (FDA) for Zaleplon Capsules.
The company has received approval for Zaleplon Capsules in the strengths of 5 mg and 10 mg, the company said in a statement.
Zaleplon capsules are generic equivalent of Kings Pharmaceuticals' Sonata Capsules.
The Company intends to launch the product in US Market shortly, it added.
UNI AK PDT KN1545